Baxter Reports Second-Quarter 2025 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. “For the second quarter of 2025, Baxter deliv...
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
Medical Equipment Maker Baxter International Names New CEO
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.
Baxter International Names Andrew Hider as CEO
Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.
Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Mo...
Baxter Stock May Gain Following Five New Injectable Product Launches
BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business segment.
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?
Investors need to pay close attention to Baxter International (BAX) stock based on the movements in the options market lately.
Baxter resumes dialysis solution production at its hurricane-hit facility
Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding.
Baxter to Present at Stifel 2024 Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxt...
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per shar...
Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe...
Baxter International (BAX) Beats Q3 Earnings Estimates
Baxter International (BAX) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.68 per share a year ago.
Baxter cuts annual profit forecast on hurricane impact
Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.
Baxter Reports Third-Quarter 2024 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2024. “Baxter delivered positive performance in the ...
Baxter restarts IV solutions manufacturing line
Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related...
Related Companies